NOTE: As provided in LFC policy, this report is intended for use by the standing finance committees of the legislature.  The Legislative Finance Committee does not assume responsibility for the accuracy of the information in this report when used in any other situation.



Only the most recent FIR version, excluding attachments, is available on the Intranet. Previously issued FIRs and attachments may be obtained from the LFC office in Suite 101 of the State Capitol Building North.





F I S C A L I M P A C T R E P O R T





SPONSOR: HCPAC DATE TYPED: 03/15/01 HB 297/HCPACS/aHAFC
SHORT TITLE: NM Prescription Drug Discount Act SB
ANALYST: Dunbar


APPROPRIATION



Appropriation Contained
Estimated Additional Impact
Recurring

or Non-Rec

Fund

Affected

FY01 FY02 FY01 FY02
$ 0.0 See Narrative



(Parenthesis ( ) Indicate Expenditure Decreases)



Relates to HB 2, HB 298, HB 299, HB300, HB 301, HB 302, HB 303, SB 98, SB 140, SB 143, and SB 144

Duplicates SB 142



REVENUE



Estimated Revenue
Subsequent

Years Impact

Recurring

or Non-Rec

Fund

Affected

FY01 FY02
See Narrative New Fund



(Parenthesis ( ) Indicate Revenue Decreases)



SOURCES OF INFORMATION



Human Services Department (HSD)

Health Policy Commission

State Agency on Aging



SUMMARY



Synopsis of HAFC Amendment



The House Appropriations and Finance Committee amendment to CS HB 297 makes the following changes:





House Bill 2 contains $3,700.0 for the program. The amount was reduced from $5,000.0 to reflect the change in income eligibility for the program. The bill as amended duplicates SB 142.



Synopsis of Substitute Bill

The bill appropriate $5 million non-recurring from the general fund to a new created Prescription Drug Discount Fund for use by the Human Services Department (HSD) for FY02 and FY03 to design and implement a prescription drug discount plan under the state's Medicaid program that would provide prescription drugs only. The bill also provides for $300,000 for 2001 and 2002 for waiver application and program administration. Unexpended and unencumbered amounts of this administrative money at the end of 2002 would revert to the general fund. The bill contains an emergency clause.



Significant Issues



Eligibility for the program would include New Mexico residency, and having an income that is less than 300% of the federal poverty level. Income definitions would be the same as those used to determine Medicaid eligibility.



The bill would require HSD to apply for an 1115 waiver no later than October 1, 2001.

The pharmacy will charge the member a price no more than the Medicaid price less an amount equal to the average rebate percentage as described in the bill. The State would pay to the pharmacy the rebate difference between the Medicaid price and the price paid by the pharmacy.



The bill creates a Prescription Drug Discount Fund in the State Treasury. All appropriations and money received for the program, including the manufacturers' rebates, would be deposited into the Fund. Money in the Fund would not revert at the end of the fiscal year. The department would administer the Fund and the Fund money would be used to reimburse the pharmacists. The bill language would limit the department to one percent of the annually received amount for program administration.



HSD would be required to publish in its monthly statistical report the number of program members, the amount of participating pharmacies, the total paid for prescription drugs under the program, the amount of manufacturers' rebates received, the volume of the top 50 prescriptions filled by type, and the average amount paid for each type.



FISCAL IMPLICATIONS



The bill appropriate $5,000.0 non-recurring from the general fund to the newly created Prescription Drug Discount Fund for FY02 and 03. The bill also provides for $300.0 for 2001 and 2002 for waiver application and program administration. This will translate into $600.0 after applying the federal match. Unexpended and unencumbered amounts of this administrative money at the end of 2002 would revert to the general fund.



Expenditures of this appropriation are contingent upon the department receiving a waiver from the federal Health Care Financing department of certain state plan provisions required pursuant to Title 19 of the federal Social Security Act.



The question needs to be asked: could this general fund appropriation result in leveraging $14 million in federal funds?



ADMINISTRATIVE IMPLICATIONS



The following concerns were expressed by HSD:



RELATIONSHIP



HB 2, General Appropriations Act of 2001

HB 298, Indians: Prescription Drugs

HB 299, Health Insurance

HB 300, Prescription Drug Senior Program

HB 301, Prescriptions: Fair Pricing Act

HB 302, Prescription Drug Program: Seniors

HB 303, Standard Co-Payments: Prescriptions

SB 98, General Appropriations Bill of 2001

SB 140, Indian Prescription Drug Purchasing

SB 143, Prescription Drug Senior Program

SB 144, Prescription Drug Bulk Purchasing



OTHER SUBSTANTIVE ISSUES



The State Agency on Aging is concerned that there are no safeguards to keep suppliers from shifting the cost burden to other consumers.



The following data was provided by the HPC:



BD/njw:ar